Corpus Intelligence IC Memo — SSH - YOUNGSTOWN 2026-04-26 10:38 UTC
IC Memo — SSH - YOUNGSTOWN
Investment Committee Memorandum | OH | 42 beds | Grade C | EBITDA uplift $1.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SSH - YOUNGSTOWN

CCN 362024 | MAHONING, OH | 42 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SSH - YOUNGSTOWN is a 42-bed suburban community hospital in MAHONING, OH with $19.6M in net patient revenue and a 5.8% operating margin. The hospital serves a payer mix of 36.4% Medicare, 7.1% Medicaid, and 56.4% commercial.

Thesis: Turnaround. Our ML models identify $1.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 5.8% to 13.2% (+736bps).

Net Revenue HCRIS$19.6M
Current EBITDA COMPUTED$1.1M
Operating Margin COMPUTED5.8%
Occupancy HCRIS68.6%
Revenue / Bed COMPUTED$467K
Net-to-Gross HCRIS15.5%
Distress Probability ML44.2%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
113
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 5.8% places it above the state median. Among 113 size-comparable peers (21-84 beds), the median margin is -1.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (21-84), prioritizing same-state peers. 113 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SSH - YOUNGSTOWN (Target)OH42$19.6M5.8%
KNOX COMMUNITY HOSPITALOH64$196.0M-16.7%
CRYSTAL CLINIC ORTHOPAEDIC CENOH59$173.3M-14.9%
THE SURGICAL HOSPITAL AT SOUTHOH24$166.6M-3.1%
OBLENESS MEMORIAL HOSPITALOH67$160.9M29.9%
MEMORIAL HOSPITAL OF UNION COUOH51$151.0M8.0%
FISHER-TITUS MEDICAL CENTEROH78$148.3M-6.9%
WESTERN RESERVE HOSPITALOH83$147.6M-9.3%
GRADY MEMORIAL HOSPITALOH60$146.7M16.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$412K+210bp18mo
Cost to Collect4.5%2.5%$392K+200bp12mo
Denial Rate Reduction12.0%6.5%$388K+198bp12mo
A/R Days Reduction5200.0%3800.0%$239K+122bp9mo
Clean Claim Rate88.0%96.0%$13K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$412K
Cost to Collect
$392K
Denial Rate Reduction
$388K
A/R Days Reduction
$239K
Clean Claim Rate
$13K
Total EBITDA Uplift$1.4M
Current EBITDA$1.1M
+ RCM Uplift+$1.4M
Pro Forma EBITDA$2.6M
Current Margin5.8%
Pro Forma Margin13.2%
WC Released (1x)$753K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$1.8M$22.0M12.47x65.6%
Base (11x exit)10.0x11.0x$1.8M$24.8M14.04x69.6%
Bull Case9.0x11.0x$1.6M$30.1M18.97x80.1%
Bull (12x exit)9.0x12.0x$1.6M$33.3M20.98x83.8%
Bear Case11.0x10.0x$1.9M$14.2M7.32x48.9%
Bear (11x exit)11.0x11.0x$1.9M$16.3M8.38x53.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 113 hospitals with 21-84 beds
  • Same-state prioritization (n=114)
  • Comp margins: P25=-12.5% / P50=-1.8% / P75=10.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.